文献速递肝病

美国非酒精性脂肪性肝病患病率、严重程度和结局的种族与民族差异:系统综述与Meta分析

Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-09-29

该系统综述与Meta分析检索截至2016年8月的MEDLINE、EMBASE和Cochrane数据库,纳入34项研究共368,569例患者,评估美国非酒精性脂肪性肝病(NAFLD)患病率、严重程度和预后的种族与民族差异。结果显示NAFLD患病率西班牙裔最高、白人居中、黑人最低,高危队列差异较小;西班牙裔NASH风险高于白人,黑人低于白人;显著纤维化比例无显著差异;结局数据有限且不一致。

要点

  • NAFLD患病率西班牙裔最高、白人居中、黑人最低,高危队列差异小于人群队列。
  • 西班牙裔NASH风险高于白人(RR 1.09,95%CI 0.98-1.21),黑人低于白人(RR 0.72,95%CI 0.60-0.87)。
  • 显著纤维化比例在种族或民族组间无显著差异,结局数据有限且不一致。

核心结论

  • 美国NAFLD患病率和严重程度存在显著种族与民族差异,西班牙裔负担最高、黑人最低,但结局数据不一致。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE和Cochrane数据库截至2016年8月,纳入34项研究共368,569例独特患者。
  • 纳入报告人群基础或高危队列NAFLD患病率、严重程度(NASH和显著纤维化)及预后(肝硬化并发症和死亡)的研究。
  • 采用DerSimonian and Laird随机效应模型计算各结局按种族和民族的合并相对风险。

主要发现

  • NAFLD患病率西班牙裔最高、白人居中、黑人最低,高危队列范围为47.6%-55.5%,人群队列范围为13.0%-22.9%。
  • NAFLD患者中,西班牙裔NASH风险高于白人(相对风险1.09,95%CI 0.98-1.21),黑人低于白人(相对风险0.72,95%CI 0.60-0.87)。
  • 显著纤维化比例在种族或民族组间无显著差异。
  • NAFLD患者结局的种族或民族差异数据有限且不一致。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • NAFLD患者结局的种族或民族差异数据有限且不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, affecting 75-100 million Americans. However, the disease burden may not be equally distributed among races or ethnicities. We conducted a systematic review and meta-analysis to characterize racial and ethnic disparities in NAFLD prevalence, severity, and prognosis. METHODS: We searched MEDLINE, EMBASE, and Cochrane databases through August 2016 for studies that reported NAFLD prevalence in population-based or high-risk cohorts, NAFLD severity including presence of nonalcoholic steatohepatitis (NASH) and significant fibrosis, and NAFLD prognosis including development of cirrhosis complications and mortality. Pooled relative risks, according to race and ethnicity, were calculated for each outcome using the DerSimonian and Laird method for a random-effects model. RESULTS: We identified 34 studies comprising 368,569 unique patients that characterized disparities in NAFLD prevalence, severity, or prognosis. NAFLD prevalence was highest in Hispanics, intermediate in Whites, and lowest in Blacks, although differences between groups were smaller in high-risk cohorts (range 47.6%-55.5%) than population-based cohorts (range, 13.0%-22.9%). Among patients with NAFLD, risk of NASH was higher in Hispanics (relative risk, 1.09; 95% CI, 0.98-1.21) and lower in Blacks (relative risk, 0.72; 95% CI, 0.60-0.87) than Whites. However, the proportion of patients with significant fibrosis did not significantly differ among racial or ethnic groups. Data were limited and discordant on racial or ethnic disparities in outcomes of patients with NAFLD. CONCLUSIONS: In a systematic review and meta-analysis, we found significant racial and ethnic disparities in NAFLD prevalence and severity in the United States, with the highest burden in Hispanics and lowest burden in Blacks. However, data are discordant on racial or ethnic differences in outcomes of patients with NAFLD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Rich NE, Oji S, Mufti AR, et al. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017. PMID: 28970148. doi:10.1016/j.cgh.2017.09.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。